Index of /command-center-prod/server/resources/views/components

[ICO]NameLast modifiedSizeDescription
[PARENTDIR]Parent Directory  -  
[DIR]altum/2024-07-03 15:40 -  
[DIR]flow-cytometry/2024-09-04 11:30 -  
[DIR]pcr/2024-11-21 11:54 -  
[DIR]suret/2024-11-21 11:54 -  
[ ]end-of-report.edge2024-04-27 15:55 124  
[ ]page-1-left-side-signatures.edge2024-04-27 15:55 207  
[ ]right-bottom-page-no.edge2024-04-27 15:55 212  
[ ]bio-fts-interpreation-footer.edge2024-04-27 15:55 235  
[ ]page-2-signatures.edge2024-04-27 15:55 255  
[ ]page-no.edge2024-04-27 15:55 262  
[ ]amh-signatures.edge2024-04-27 15:55 372  
[ ]sujanan-footer.edge2024-04-27 15:55 445  
[ ]header-barcode-patientname-cyto.edge2024-04-27 15:55 449  
[ ]thal-signatures.edge2024-08-19 21:29 501  
[ ]page-1-signatures.edge2024-04-27 15:55 605  
[ ]sure-t-patient-name-id.edge2024-04-27 15:55 620  
[ ]cariem-impression-suggesion.edge2024-04-27 15:55 632  
[ ]floating-page-no.edge2024-04-27 15:55 686  
[ ]light-purple-interpretation-and-suggestions.edge2024-04-27 15:55 715  
[ ]dark-purple-interpretation-and-suggestions.edge2024-04-27 15:55 761  
[ ]footer.edge2024-04-27 15:55 808  
[ ]nipt-patient-info-small.edge2024-04-27 15:55 824  
[ ]header-barcode-patientname.edge2024-04-27 15:55 827  
[ ]nipt-signatures.edge2024-07-03 15:40 874  
[ ]sflt-interpretations-and-suggestions.edge2024-04-27 15:55 1.0K 
[ ]cariem-intro.edge2024-04-27 15:55 1.0K 
[ ]sflt-notes.edge2024-04-27 15:55 1.0K 
[ ]nipt-methodology-content.edge2024-04-27 15:55 1.2K 
[ ]notes.edge2024-04-27 15:55 1.3K 
[ ]remaining-metabolics-in-blood.edge2024-04-27 15:55 1.3K 
[ ]nips-background.edge2024-04-27 15:55 1.5K 
[ ]cyto-page1-images.edge2024-04-27 15:55 1.6K 
[ ]cyto-page2-images.edge2024-04-27 15:55 1.6K 
[ ]nipt-remaining-references.edge2024-04-27 15:55 1.6K 
[ ]nipt-patient-information.edge2024-04-27 15:55 2.2K 
[ ]signatures.edge2024-04-27 15:55 2.2K 
[ ]metabolics-in-blood.edge2024-04-27 15:55 2.5K 
[ ]thal-vertical-patient-info.edge2024-04-27 15:55 2.6K 
[ ]significance-of-multiple-mom.edge2024-04-27 15:55 2.7K 
[ ]nipt-clinical-performance.edge2024-04-27 15:55 2.7K 
[ ]the-cariem-expplus-advantage.edge2024-04-27 15:55 2.8K 
[ ]sflt1-plgf-ratio.edge2024-04-27 15:55 2.9K 
[ ]the-cariem-advantage.edge2024-04-27 15:55 3.1K 
[ ]evico-risk-assessment-method.edge2024-04-27 15:55 3.3K 
[ ]sflt-test-finding.edge2024-04-27 15:55 3.5K 
[ ]nipt-references.edge2024-04-27 15:55 3.7K 
[ ]cariem-understanding-interpreting-page.edge2024-04-27 15:55 3.8K 
[ ]nipt-static-page3.edge2024-04-27 15:55 4.9K 
[ ]test-bio-values.edge2024-04-27 15:55 5.1K 
[ ]cyto-interpretations-recommendations.edge2024-04-27 15:55 5.4K 
[ ]cyto-frontpage-patient-info.edge2024-04-27 15:55 5.5K 
[ ]sflt-result.edge2024-04-27 15:55 5.8K 
[ ]thal-hb-values.edge2024-04-27 15:55 6.0K 
[ ]thal_cbc_parameters.edge2024-04-27 15:55 6.1K 
[ ]interpretation-of-few-metabolites.edge2024-04-27 15:55 6.6K 
[ ]prenatal-screening-background.edge2024-04-27 15:55 7.6K 
[ ]interpretation-and-suggestions.edge2024-04-27 15:55 8.3K 
[ ]cariem-history-and-parameters.edge2024-04-27 15:55 10K 
[ ]evico-screen-intro.edge2024-04-27 15:55 13K 
[ ]disclaimers.edge2024-04-27 15:55 19K 
[ ]result-analysis.edge2024-04-27 15:55 20K 
[ ]frontpage-patient-info.edge2024-05-13 22:25 26K 
[ ]pregnancy-details.edge2024-05-13 22:25 33K 
[ ]risk-assessment-and-mom.edge2024-04-27 15:55 46K 
[ ]specimen-details.edge2024-04-27 15:55 50K 
[ ]risks-syndromes.edge2024-04-27 15:55 53K 
Apache/2.4.41 (Ubuntu) Server at 3.7.45.13 Port 443